The Food and Drug Administration has approved new booster shots by both Pfizer and Moderna. These shots are supposedly designed to target the XBB.1.5 subvariant (which is no longer dominant) and are expected to be made available later this week.
Even though the COVID-19 virus has mutated, the ruling class and big pharma are adamant that these new injections will ward off the new variants. Health officials say that the Centers for Disease Control and Prevention will now sign off on it amid rising cases of Covid across the United States.
Last week Moderna released a statement saying the company’s updated boosters are expected to work well against the BA.2.86 variant which is unofficially called “Pirola”.
Covid-19 case counts are rising across the US, and public health authorities are monitoring the worrisome new variant. Some experts are urging Americans to wear a mask when necessary to slow the spread of the virus.
According to a report by The Independent, doctors warned that Pirola may be cause for concern as it is a newly designated, highly-mutated variant of Omicron which triggered a surge in cases in a number of countries including the U.S. According to a Thursday bulletin in Yale Medicine, the new variant has more than 30 mutations to its spike protein (located on the outer surface of a coronavirus) which helps it enter and infect human cells.
The rulers are going to insist that everyone get injected with these new shots too. We already know that mass vaccination was the goal of the COVID plandemic.
The FDA said in a statement on Monday that anyone over the age of five is eligible to receive a single dose of the updated vaccine if it is at least two months since their last dose of any other COVID-19 vaccine. “Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death,” said Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.
“The public can be assured that these updated vaccines have met the agency’s rigorous scientific standards for safety, effectiveness, and manufacturing quality. We very much encourage those who are eligible to consider getting vaccinated.”